Both in Pharmaceuticals
Turn Therapeutics vs Opus Genetics
Over the past year TTRX returned +91.6% and IRD returned +141.7%; their daily moves had a correlation of 0.00.
TTRX +91.6% IRD +141.7%Growth of $1, one year, split-adjusted
| Metric | TTRX | IRD |
|---|---|---|
| Price | $13.41 | $4.96 |
| Market cap | $407.2M | $412.2M |
| Today | +2.84% | −1.88% |
| 1 month | +36.3% | +34.3% |
| 6 months | +316.5% | +13.9% |
| Year to date | +240.4% | +146.5% |
| 1 year | — | +172.3% |
| Revenue growth (YoY) | — | −73.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1072.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 41.8× |
| Net cash | $4.2M | $53.9M |
| Dividend yield | — | — |
| Volatility (60d) | 104.2% | 90.3% |
| Short % of float | 1.3% | 20.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).